Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase
Identifieur interne : 000656 ( Istex/Corpus ); précédent : 000655; suivant : 000657Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase
Auteurs : Igor Vo Echovsk ; Liping Luo ; Geneviève De Saint Basile ; Lennart Hammarström ; A. David B. Webster ; C. I. Edvard SmithSource :
- Human Molecular Genetics [ 0964-6906 ] ; 1995-12.
Url:
DOI: 10.1093/hmg/4.12.2403
Links to Exploration step
ISTEX:0B3A2503C6106C73900F6F017EDBE531B0BAD0D5Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase</title><author><name sortKey="Vo Echovsk, Igor" sort="Vo Echovsk, Igor" uniqKey="Vo Echovsk I" first="Igor" last="Vo Echovsk">Igor Vo Echovsk</name><affiliation><mods:affiliation>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</mods:affiliation></affiliation><affiliation><mods:affiliation>To whom correspondence should be addressed at: Karolinska Institute at NOVUM, Center for BioTechnology, S-14157 Huddinge, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Luo, Liping" sort="Luo, Liping" uniqKey="Luo L" first="Liping" last="Luo">Liping Luo</name><affiliation><mods:affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</mods:affiliation></affiliation></author><author><name sortKey="De Saint Basile, Genevieve" sort="De Saint Basile, Genevieve" uniqKey="De Saint Basile G" first="Geneviève" last="De Saint Basile">Geneviève De Saint Basile</name><affiliation><mods:affiliation>INSERM 132, Hôpital Necker-Enfants-Malades F-75743 Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Hammarstrom, Lennart" sort="Hammarstrom, Lennart" uniqKey="Hammarstrom L" first="Lennart" last="Hammarström">Lennart Hammarström</name><affiliation><mods:affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Webster, A David B" sort="Webster, A David B" uniqKey="Webster A" first="A. David B." last="Webster">A. David B. Webster</name><affiliation><mods:affiliation>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</mods:affiliation></affiliation></author><author><name sortKey="Smith, C I Edvard" sort="Smith, C I Edvard" uniqKey="Smith C" first="C. I. Edvard" last="Smith">C. I. Edvard Smith</name><affiliation><mods:affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0B3A2503C6106C73900F6F017EDBE531B0BAD0D5</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1093/hmg/4.12.2403</idno><idno type="url">https://api.istex.fr/document/0B3A2503C6106C73900F6F017EDBE531B0BAD0D5/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000656</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000656</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase</title><author><name sortKey="Vo Echovsk, Igor" sort="Vo Echovsk, Igor" uniqKey="Vo Echovsk I" first="Igor" last="Vo Echovsk">Igor Vo Echovsk</name><affiliation><mods:affiliation>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</mods:affiliation></affiliation><affiliation><mods:affiliation>To whom correspondence should be addressed at: Karolinska Institute at NOVUM, Center for BioTechnology, S-14157 Huddinge, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Luo, Liping" sort="Luo, Liping" uniqKey="Luo L" first="Liping" last="Luo">Liping Luo</name><affiliation><mods:affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</mods:affiliation></affiliation></author><author><name sortKey="De Saint Basile, Genevieve" sort="De Saint Basile, Genevieve" uniqKey="De Saint Basile G" first="Geneviève" last="De Saint Basile">Geneviève De Saint Basile</name><affiliation><mods:affiliation>INSERM 132, Hôpital Necker-Enfants-Malades F-75743 Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Hammarstrom, Lennart" sort="Hammarstrom, Lennart" uniqKey="Hammarstrom L" first="Lennart" last="Hammarström">Lennart Hammarström</name><affiliation><mods:affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Webster, A David B" sort="Webster, A David B" uniqKey="Webster A" first="A. David B." last="Webster">A. David B. Webster</name><affiliation><mods:affiliation>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</mods:affiliation></affiliation></author><author><name sortKey="Smith, C I Edvard" sort="Smith, C I Edvard" uniqKey="Smith C" first="C. I. Edvard" last="Smith">C. I. Edvard Smith</name><affiliation><mods:affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Human Molecular Genetics</title><idno type="ISSN">0964-6906</idno><idno type="eISSN">1460-2083</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="1995-12">1995-12</date><biblScope unit="volume">4</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="2403">2403</biblScope><biblScope unit="page" to="2405">2405</biblScope></imprint><idno type="ISSN">0964-6906</idno></series><idno type="istex">0B3A2503C6106C73900F6F017EDBE531B0BAD0D5</idno><idno type="DOI">10.1093/hmg/4.12.2403</idno><idno type="ArticleID">4.12.2403</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0964-6906</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><istex><corpusName>oup</corpusName><author><json:item><name>Igor Vořechovský</name><affiliations><json:string>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</json:string><json:string>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</json:string><json:string>To whom correspondence should be addressed at: Karolinska Institute at NOVUM, Center for BioTechnology, S-14157 Huddinge, Sweden</json:string></affiliations></json:item><json:item><name>Liping Luo</name><affiliations><json:string>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</json:string></affiliations></json:item><json:item><name>Geneviève de Saint Basile</name><affiliations><json:string>INSERM 132, Hôpital Necker-Enfants-Malades F-75743 Paris, France</json:string></affiliations></json:item><json:item><name>Lennart Hammarström</name><affiliations><json:string>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</json:string></affiliations></json:item><json:item><name>A.David B. Webster</name><affiliations><json:string>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</json:string></affiliations></json:item><json:item><name>C.I.Edvard Smith</name><affiliations><json:string>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</json:string></affiliations></json:item></author><subject><json:item><value>MUTATION REPORTS</value></json:item></subject><articleId><json:string>4.12.2403</json:string></articleId><language><json:string>unknown</json:string></language><originalGenre><json:string>other</json:string></originalGenre><qualityIndicators><score>4.2</score><pdfVersion>1.2</pdfVersion><pdfPageSize>609 x 802 pts</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>1</keywordCount><abstractCharCount>0</abstractCharCount><pdfWordCount>2188</pdfWordCount><pdfCharCount>13317</pdfCharCount><pdfPageCount>3</pdfPageCount><abstractWordCount>1</abstractWordCount></qualityIndicators><title>Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase</title><refBibs><json:item><author></author><host><volume>4</volume><pages><first>2405</first></pages><issue>12</issue><author></author><title>Human Molecular Genetics</title><publicationDate>1995</publicationDate></host><publicationDate>1995</publicationDate></json:item><json:item><author><json:item><name>L,A D Bradley</name></json:item><json:item><name>A,K Sweatman</name></json:item><json:item><name>R,C Lovering</name></json:item><json:item><name>A,M Jones</name></json:item><json:item><name>G Morgan</name></json:item><json:item><name>R,J Levinsky</name></json:item><json:item><name>C Kinnon</name></json:item></author><host><volume>3</volume><pages><last>83</last><first>79</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1994</publicationDate></host><title>Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>M De Weers</name></json:item><json:item><name>R,G J Mensink</name></json:item><json:item><name>M,E M Kraakman</name></json:item><json:item><name>R,K B Schuurman</name></json:item><json:item><name>R,W Hendriks</name></json:item></author><host><volume>3</volume><pages><last>166</last><first>161</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1994</publicationDate></host><title>Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>I Vorechovsky</name></json:item><json:item><name>M Vihinen</name></json:item><json:item><name> De Saint</name></json:item><json:item><name>G Basile</name></json:item><json:item><name>S Honsova</name></json:item><json:item><name>L Hammarstrom</name></json:item><json:item><name>S Miiller</name></json:item><json:item><name>L Nilsson</name></json:item><json:item><name>A Fischer</name></json:item><json:item><name>C,I E Smith</name></json:item></author><host><volume>4</volume><pages><last>58</last><first>51</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1995</publicationDate></host><title>DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agamma-globulinaemia</title><publicationDate>1995</publicationDate></json:item><json:item><author><json:item><name>Q Zhu</name></json:item><json:item><name>M Zhang</name></json:item><json:item><name>J Winkelstein</name></json:item><json:item><name>S-H Chen</name></json:item><json:item><name>H Ochs</name></json:item></author><host><volume>3</volume><pages><last>1900</last><first>1899</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1994</publicationDate></host><title>Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>D,C Saffran</name></json:item><json:item><name>O Parolini</name></json:item><json:item><name>M,E Hilgenberg-Fitch</name></json:item><json:item><name>D,J Rawlings</name></json:item><json:item><name>D,E H Afar</name></json:item><json:item><name>O Witte</name></json:item><json:item><name>M,E Conley</name></json:item></author><host><volume>330</volume><pages><last>1491</last><first>1488</first></pages><author></author><title>N. Engl. J. Med</title><publicationDate>1994</publicationDate></host><title>Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>M Vihinen</name></json:item><json:item><name>D Vetrie</name></json:item><json:item><name>H Maniar</name></json:item><json:item><name>H Ochs</name></json:item><json:item><name>Q Zhu</name></json:item><json:item><name>I Vorechovsky</name></json:item><json:item><name>A,D B Webster</name></json:item><json:item><name>L Notarangelo</name></json:item><json:item><name>L Nilsson</name></json:item><json:item><name>J Sowadski</name></json:item><json:item><name>C,I E Smith</name></json:item></author><host><pages><last>12807</last><first>12803</first></pages><author></author><title>Proc. Natl Acad. Sci. USA 91</title><publicationDate>1994</publicationDate></host><title>Structural basis for X-linked agammaglobulinemia. A tyrosine kinase disease</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>H Jin</name></json:item><json:item><name>A,D B Webster</name></json:item><json:item><name>M Vihinen</name></json:item><json:item><name>P Sideras</name></json:item><json:item><name>I Vorechovsky</name></json:item><json:item><name>L Hammarstrom</name></json:item><json:item><name>E Bematowska-Matuszkiewicz</name></json:item><json:item><name>C,I E Smith</name></json:item><json:item><name>M Bobrow</name></json:item><json:item><name>D Vetrie</name></json:item></author><host><volume>4</volume><pages><last>700</last><first>693</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1995</publicationDate></host><title>Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA)</title><publicationDate>1995</publicationDate></json:item><json:item><author><json:item><name>H Gaspar</name></json:item><json:item><name>L,A D Bradley</name></json:item><json:item><name>F Katz</name></json:item><json:item><name>R,C Lovering</name></json:item><json:item><name>C,M Roifman</name></json:item><json:item><name>G Morgan</name></json:item><json:item><name>R,J Levinsky</name></json:item><json:item><name>C Kinnon</name></json:item></author><host><volume>4</volume><pages><last>757</last><first>755</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1995</publicationDate></host><title>Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot</title><publicationDate>1995</publicationDate></json:item><json:item><author><json:item><name>M,E Conley</name></json:item><json:item><name>M,E Fitch-Hilgenberg</name></json:item><json:item><name>J,L Cleveland</name></json:item><json:item><name>O Parolini</name></json:item><json:item><name>J Rohrer</name></json:item></author><host><volume>3</volume><pages><last>1756</last><first>1751</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1994</publicationDate></host><title>Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>M Vihinen</name></json:item><json:item><name>T Iwata</name></json:item><json:item><name>C Kinnon</name></json:item><json:item><name>S.-R Kwan</name></json:item><json:item><name>H Ochs</name></json:item><json:item><name>I Vorechovsky</name></json:item><json:item><name>C,I E Smith</name></json:item></author><host><author></author><title>Nucleic Acids Res</title><publicationDate>1996</publicationDate></host><title>BTKbase, mutation database for X-linked agammaglobulinaemia</title><publicationDate>1996</publicationDate></json:item><json:item><author><json:item><name>T,L Hagemann</name></json:item><json:item><name>Y Chen</name></json:item><json:item><name>F,S Rosen</name></json:item><json:item><name>S-P Kwan</name></json:item></author><host><volume>3</volume><pages><last>1749</last><first>1743</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1994</publicationDate></host><title>Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>Y Ohta</name></json:item><json:item><name>R,N Haire</name></json:item><json:item><name>R,T Litman</name></json:item><json:item><name>S,M Fu</name></json:item><json:item><name>R,P Nelson</name></json:item><json:item><name>J Kratz</name></json:item><json:item><name>S,J Kornfeld</name></json:item><json:item><name>M De La Morena</name></json:item><json:item><name>R,A Good</name></json:item><json:item><name>G,W Litman</name></json:item></author><host><pages><last>9066</last><first>9062</first></pages><author></author><title>Proc. Natl Acad. Sci. USA 91</title><publicationDate>1994</publicationDate></host><title>Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X-chromosome linked agammaglobulinemia</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>T Hagemann</name></json:item><json:item><name>F,S Rosen</name></json:item><json:item><name>S-P Kwan</name></json:item></author><host><volume>5</volume><pages><last>302</last><first>296</first></pages><author></author><title>Hum. Mutat</title><publicationDate>1995</publicationDate></host><title>Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinaemia</title><publicationDate>1995</publicationDate></json:item><json:item><author><json:item><name>J Rohrer</name></json:item><json:item><name>O Parolini</name></json:item><json:item><name>J,W Belmont</name></json:item><json:item><name>M,E Conley</name></json:item></author><host><volume>40</volume><pages><last>324</last><first>319</first></pages><author></author><title>Immunogenetics</title><publicationDate>1994</publicationDate></host><title>The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>P Sideras</name></json:item><json:item><name>S Miiller</name></json:item><json:item><name>H Shiels</name></json:item><json:item><name>H Jin</name></json:item><json:item><name>W Khan</name></json:item><json:item><name>L Nilsson</name></json:item><json:item><name>E Parkinson</name></json:item><json:item><name>J,D Thomas</name></json:item><json:item><name>L Branden</name></json:item><json:item><name>I Larsson</name></json:item><json:item><name>W,E Paul</name></json:item><json:item><name>F,S Rosen</name></json:item><json:item><name>F,W Alt</name></json:item><json:item><name>D Vetrie</name></json:item><json:item><name>C,I E Smith</name></json:item><json:item><name>K,G Xanthopoulos</name></json:item></author><host><volume>153</volume><pages><last>5617</last><first>5607</first></pages><author></author><title>J. Immunol</title><publicationDate>1994</publicationDate></host><title>Genomic organisation of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>I Vorechovsky</name></json:item></author><host><volume>3</volume><pages><first>1031</first></pages><author></author><title>Hum. Mol. Genet</title><publicationDate>1994</publicationDate></host><title>SSCP at the BTK locus</title><publicationDate>1994</publicationDate></json:item><json:item><author><json:item><name>D Vetrie</name></json:item><json:item><name>I Vorechovsky</name></json:item><json:item><name>P Sideras</name></json:item><json:item><name>J Holland</name></json:item><json:item><name>A Davies</name></json:item><json:item><name>F Flinter</name></json:item><json:item><name>L Hammarstrom</name></json:item><json:item><name>C Kinnon</name></json:item><json:item><name>R Levinsky</name></json:item><json:item><name>M Bobrow</name></json:item><json:item><name>C,1 E Smith</name></json:item><json:item><name>D Bentley</name></json:item></author><host><volume>361</volume><pages><last>233</last><first>226</first></pages><author></author><title>Nature</title><publicationDate>1993</publicationDate></host><title>The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases</title><publicationDate>1993</publicationDate></json:item></refBibs><genre><json:string>other</json:string></genre><host><volume>4</volume><publisherId><json:string>hmg</json:string></publisherId><pages><last>2405</last><first>2403</first></pages><issn><json:string>0964-6906</json:string></issn><issue>12</issue><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1460-2083</json:string></eissn><title>Human Molecular Genetics</title></host><categories><wos><json:string>science</json:string><json:string>genetics & heredity</json:string><json:string>biochemistry & molecular biology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>biomedical research</json:string><json:string>genetics & heredity</json:string></scienceMetrix></categories><publicationDate>1995</publicationDate><copyrightDate>1995</copyrightDate><doi><json:string>10.1093/hmg/4.12.2403</json:string></doi><id>0B3A2503C6106C73900F6F017EDBE531B0BAD0D5</id><score>0.12133905</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/0B3A2503C6106C73900F6F017EDBE531B0BAD0D5/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/0B3A2503C6106C73900F6F017EDBE531B0BAD0D5/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/0B3A2503C6106C73900F6F017EDBE531B0BAD0D5/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase</title><respStmt><resp>Références bibliographiques récupérées via GROBID</resp><name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Oxford University Press</publisher><availability><p>© 1995 Oxford University Press</p></availability><date>1995</date></publicationStmt><notesStmt><note>*To whom correspondence should be addressed at: Karolinska Institute at NOVUM, Center for BioTechnology, S-14157 Huddinge, Sweden</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase</title><author xml:id="author-1"><persName><forename type="first">Igor</forename><surname>Vořechovský</surname></persName><affiliation>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</affiliation><affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</affiliation><affiliation>To whom correspondence should be addressed at: Karolinska Institute at NOVUM, Center for BioTechnology, S-14157 Huddinge, Sweden</affiliation></author><author xml:id="author-2"><persName><forename type="first">Liping</forename><surname>Luo</surname></persName><affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</affiliation></author><author xml:id="author-3"><persName><forename type="first">Geneviève</forename><surname>de Saint Basile</surname></persName><affiliation>INSERM 132, Hôpital Necker-Enfants-Malades F-75743 Paris, France</affiliation></author><author xml:id="author-4"><persName><forename type="first">Lennart</forename><surname>Hammarström</surname></persName><affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</affiliation></author><author xml:id="author-5"><persName><forename type="first">A.David B.</forename><surname>Webster</surname></persName><affiliation>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</affiliation></author><author xml:id="author-6"><persName><forename type="first">C.I.Edvard</forename><surname>Smith</surname></persName><affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</affiliation></author></analytic><monogr><title level="j">Human Molecular Genetics</title><idno type="pISSN">0964-6906</idno><idno type="eISSN">1460-2083</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="1995-12"></date><biblScope unit="volume">4</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="2403">2403</biblScope><biblScope unit="page" to="2405">2405</biblScope></imprint></monogr><idno type="istex">0B3A2503C6106C73900F6F017EDBE531B0BAD0D5</idno><idno type="DOI">10.1093/hmg/4.12.2403</idno><idno type="ArticleID">4.12.2403</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1995</date></creation><textClass><keywords scheme="keyword"><list><item><term>MUTATION REPORTS</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1995-12">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-12-22">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/0B3A2503C6106C73900F6F017EDBE531B0BAD0D5/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus oup" wicri:toSee="no header"><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="other"><front><journal-meta><journal-id journal-id-type="hwp">hmg</journal-id><journal-id journal-id-type="publisher-id">hmg</journal-id><journal-id journal-id-type="pmc">hmg</journal-id><journal-title>Human Molecular Genetics</journal-title><issn pub-type="epub">1460-2083</issn><issn pub-type="ppub">0964-6906</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4.12.2403</article-id><article-id pub-id-type="doi">10.1093/hmg/4.12.2403</article-id><article-categories><subj-group><subject>MUTATION REPORTS</subject></subj-group></article-categories><title-group><article-title>Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vořechovský</surname><given-names>Igor</given-names></name><xref ref-type="aff" rid="au1"><sup>1</sup></xref><xref ref-type="aff" rid="au2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Luo</surname><given-names>Liping</given-names></name><xref ref-type="aff" rid="au2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>de Saint Basile</surname><given-names>Geneviève</given-names></name><xref ref-type="aff" rid="au3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hammarström</surname><given-names>Lennart</given-names></name><xref ref-type="aff" rid="au2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Webster</surname><given-names>A.David B.</given-names></name><xref ref-type="aff" rid="au1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>C.I.Edvard</given-names></name><xref ref-type="aff" rid="au2"><sup>2</sup></xref></contrib><aff id="au1"><sup>1</sup><institution>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine</institution> <addr-line>Rowland Hill Street, London NW3 2PF. UK</addr-line></aff><aff id="au2"><sup>2</sup><institution>Karolinska Institute at NOVUM, Center for BioTechnology</institution> <addr-line>S-14157 Huddinge, Sweden</addr-line></aff><aff id="au3"><sup>3</sup><institution>INSERM 132, Hôpital Necker-Enfants-Malades</institution> <addr-line>F-75743 Paris, France</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><sup>*</sup>To whom correspondence should be addressed at: Karolinska Institute at NOVUM, Center for BioTechnology, S-14157 Huddinge, Sweden</corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>1995</year></pub-date><volume>4</volume><issue>12</issue><fpage>2403</fpage><lpage>2405</lpage><history><date date-type="received"><day>14</day><month>7</month><year>1995</year></date><date date-type="rev-recd"><day>06</day><month>9</month><year>1995</year></date><date date-type="accepted"><day>06</day><month>9</month><year>1995</year></date></history><copyright-statement>© 1995 Oxford University Press</copyright-statement><copyright-year>1995</copyright-year></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase</title></titleInfo><name type="personal"><namePart type="given">Igor</namePart><namePart type="family">Vořechovský</namePart><affiliation>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</affiliation><affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</affiliation><affiliation>To whom correspondence should be addressed at: Karolinska Institute at NOVUM, Center for BioTechnology, S-14157 Huddinge, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Liping</namePart><namePart type="family">Luo</namePart><affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Geneviève</namePart><namePart type="family">de Saint Basile</namePart><affiliation>INSERM 132, Hôpital Necker-Enfants-Malades F-75743 Paris, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Lennart</namePart><namePart type="family">Hammarström</namePart><affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.David B.</namePart><namePart type="family">Webster</namePart><affiliation>MRC Immunodeficiency Research Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF. UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.I.Edvard</namePart><namePart type="family">Smith</namePart><affiliation>Karolinska Institute at NOVUM, Center for BioTechnology S-14157 Huddinge, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="other" displayLabel="other"></genre><subject><topic>MUTATION REPORTS</topic></subject><originInfo><publisher>Oxford University Press</publisher><dateIssued encoding="w3cdtf">1995-12</dateIssued><copyrightDate encoding="w3cdtf">1995</copyrightDate></originInfo><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><note type="author-notes">*To whom correspondence should be addressed at: Karolinska Institute at NOVUM, Center for BioTechnology, S-14157 Huddinge, Sweden</note><relatedItem type="host"><titleInfo><title>Human Molecular Genetics</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0964-6906</identifier><identifier type="eISSN">1460-2083</identifier><identifier type="PublisherID">hmg</identifier><identifier type="PublisherID-hwp">hmg</identifier><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><detail type="issue"><caption>no.</caption><number>12</number></detail><extent unit="pages"><start>2403</start><end>2405</end></extent></part></relatedItem><identifier type="istex">0B3A2503C6106C73900F6F017EDBE531B0BAD0D5</identifier><identifier type="DOI">10.1093/hmg/4.12.2403</identifier><identifier type="ArticleID">4.12.2403</identifier><accessCondition type="use and reproduction" contentType="copyright">© 1995 Oxford University Press</accessCondition><recordInfo><recordContentSource>OUP</recordContentSource></recordInfo></mods></metadata><annexes><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/0B3A2503C6106C73900F6F017EDBE531B0BAD0D5/annexes/pdf</uri></json:item></annexes><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000656 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000656 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:0B3A2503C6106C73900F6F017EDBE531B0BAD0D5
|texte= Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase
}}
| This area was generated with Dilib version V0.6.29. |  |